Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Fukuda

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 21, 2020
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxelNaoki Fukuda, Yu Fujiwara, Xiaofei Wang, et al.
Anticancer Research|March 31, 2021
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With LenvatinibNaoki Fukuda, Kazuhisa Toda, Akihiro Ohmoto, et al.
Oncotarget|July 9, 2020
Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trialToshiyasu Ojima, Masaki Nakamura, Keiji Hayata, et al.
Internal Medicine (Tokyo, Japan)|March 1, 2022
Heterotopic Gastric Mucosa in Middle Esophagus Complicated with Esophageal UlcersKenichi Kishimoto, Kotaro Shibagaki, Saya Nonomura, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Non-occlusive mesenteric ischemia after splenic metastasectomy for small-cell lung cancerHiromichi Yamane, Naoki Fukuda, Ken Nishino, et al.
Oncology|July 10, 2023
Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and NeckNaoki Fukuda, Ryosuke Oki, Hirotaka Suto, et al.
BMC Cancer|July 5, 2019
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective studyHiroyuki Arai, Satoru Iwasa, Narikazu Boku, et al.
Journal of Geriatric Oncology|May 25, 2023
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatinYu Fujiwara, Yasuyoshi Sato, Naomi Hayashi, et al.
International Journal of Clinical Oncology|September 16, 2017
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinomaSatoshi Murahashi, Daisuke Takahari, Takeru Wakatsuki, et al.
Oncotarget|April 11, 2018
Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxelNaoki Fukuda, Daisuke Takahari, Takeru Wakatsuki, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 21, 2020
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxelNaoki Fukuda, Yu Fujiwara, Xiaofei Wang, et al.
Anticancer Research|March 31, 2021
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With LenvatinibNaoki Fukuda, Kazuhisa Toda, Akihiro Ohmoto, et al.
Oncotarget|July 9, 2020
Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trialToshiyasu Ojima, Masaki Nakamura, Keiji Hayata, et al.
Internal Medicine (Tokyo, Japan)|March 1, 2022
Heterotopic Gastric Mucosa in Middle Esophagus Complicated with Esophageal UlcersKenichi Kishimoto, Kotaro Shibagaki, Saya Nonomura, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Non-occlusive mesenteric ischemia after splenic metastasectomy for small-cell lung cancerHiromichi Yamane, Naoki Fukuda, Ken Nishino, et al.
Oncology|July 10, 2023
Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and NeckNaoki Fukuda, Ryosuke Oki, Hirotaka Suto, et al.
BMC Cancer|July 5, 2019
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective studyHiroyuki Arai, Satoru Iwasa, Narikazu Boku, et al.
Journal of Geriatric Oncology|May 25, 2023
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatinYu Fujiwara, Yasuyoshi Sato, Naomi Hayashi, et al.
International Journal of Clinical Oncology|September 16, 2017
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinomaSatoshi Murahashi, Daisuke Takahari, Takeru Wakatsuki, et al.
Oncotarget|April 11, 2018
Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxelNaoki Fukuda, Daisuke Takahari, Takeru Wakatsuki, et al.
Pageof 11